About: Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.08 (+0.83%)
ACXP NASDAQ Acurx Pharmaceuticals LLC
Acurx Pharmaceuticals LLC share price
Atividade de preço de ACXP
Último preço
$ 1,080
Variação (24h)
0,01 USD (0,83%)
Volume
64.21K
Volume (média 4 sem.)
-
Abertura
$ 1,07
Variação do dia
$ 1,06 - $ 1,11
Fechamento anterior
$ 1,07
Último negócio
29 Oct, 7:41 pm GMT+0
Atrasado
29 Oct, 7:41 pm GMT+0
ACXP price performance
Atrasado
29 Oct, 7:41 pm GMT+0
quote.marketSignals